Abbott India Q1 net up 17% at Rs 31.70 cr
New Delhi: Drug firm Abbott India Thursday said its net profit rose by 17.06 percent to Rs 31.70 crore for the first quarter ended March 31, 2013.
The company had posted a net profit of Rs 27.08 crore for the same period in previous year, Abbott India said in a BSE filing.
The Mumbai-based firm follows January-December fiscal year.
Net sales of the company rose to Rs 406.52 crore for the first quarter as against Rs 366.44 crore during the same period of previous year.
The company said its shareholders have approved a dividend of Rs 17 per share for the year ended December 31, 2012, which would entail an outgo of Rs 42.26 crore.
The company, which is a subsidiary of Abbott Laboratories, has presence in various therapeutic categories such as women's health, gastroenterology, neurology, thyroid and diabetes.
Shares of Abbott India Thursday closed at Rs 1,378.95 on the BSE, up 0.28 percent from their previous close.